---
title: "IDE pivotal trial for novel liquid embolic device completes enrolment"
date: "2026-01-07T15:00:34.000Z"
publishedDate: "7 janvier 2026"
summary: "Fluidx Medical Technology has announced completion of patient enrolment in the investigational device exemption (IDE) pivotal clinical trial evaluating the GPX embolic device. The prospective, multicentre, multinational study is designed to assess the safety and effectiveness of GPX for peripheral vascular embolization."
importance: ""
sourceUrl: "https://interventionalnews.com/ide-pivotal-trial-for-novel-liquid-embolic-device-completes-enrolment/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2026-01-07-ide-pivotal-trial-for-novel-liquid-embolic-device-completes-enrolment"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2026/01/GPX-Syringe-Image-scaled.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/ide-pivotal-trial-for-novel-liquid-embolic-device-completes-enrolment/"
---

![IDE pivotal trial for novel liquid embolic device completes enrolment](https://interventionalnews.com/wp-content/uploads/sites/13/2026/01/GPX-Syringe-Image-scaled.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/ide-pivotal-trial-for-novel-liquid-embolic-device-completes-enrolment/*

## L’essentiel

Fluidx Medical Technology has announced completion of patient enrolment in the investigational device exemption (IDE) pivotal clinical trial evaluating the GPX embolic device. The prospective, multicentre, multinational study is designed to assess the safety and effectiveness of GPX for peripheral vascular embolization.

## Lien source

https://interventionalnews.com/ide-pivotal-trial-for-novel-liquid-embolic-device-completes-enrolment/
